Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

First Wave of COVID-19 in French Patients with Cystic Fibrosis
Harriet Corvol, Sandra de Miranda, Lydie Lemonnier, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 11, pp. 3624-3624
Open Access | Times Cited: 40

Showing 1-25 of 40 citing articles:

SARS-CoV-2 viral entry and replication is impaired in Cystic Fibrosis airways due to ACE2 downregulation
Valentino Bezzerri, Valentina Gentili, Martina Api, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 28
Incidence of SARS-CoV-2 in people with cystic fibrosis in Europe between February and June 2020
Lutz Naehrlich, Annalisa Orenti, Fiona Dunlevy, et al.
Journal of Cystic Fibrosis (2021) Vol. 20, Iss. 4, pp. 566-577
Open Access | Times Cited: 50
Systematic review: cystic fibrosis in the SARS-CoV-2/COVID-19 pandemic
Hannah R. Mathew, May Y. Choi, Michael D. Parkins, et al.
BMC Pulmonary Medicine (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 42
The efficacy of COVID-19 vaccination in cystic fibrosis patients: a systematic review
Azam Gholami Shahrebabak, Masoud Rezaei, Amirhossein Shahpar, et al.
BMC Infectious Diseases (2025) Vol. 25, Iss. 1
Open Access
CFTR Inhibitors Display In Vitro Antiviral Activity against SARS-CoV-2
Anna Lagni, Virginia Lotti, Erica Diani, et al.
Cells (2023) Vol. 12, Iss. 5, pp. 776-776
Open Access | Times Cited: 10
SARS-CoV-2 infections in people with primary ciliary dyskinesia: neither frequent, nor particularly severe
Eva S.L. Pedersen, Myrofora Goutaki, Amanda Harris, et al.
European Respiratory Journal (2021) Vol. 58, Iss. 2, pp. 2004548-2004548
Open Access | Times Cited: 26
Factors for severe outcomes following SARS-CoV-2 infection in people with cystic fibrosis in Europe
Andreas Jung, Annalisa Orenti, Fiona Dunlevy, et al.
ERJ Open Research (2021) Vol. 7, Iss. 4, pp. 00411-2021
Open Access | Times Cited: 24
Immunogenicity and Safety of the BNT162b2 COVID-19 Vaccine in Patients with Cystic Fibrosis with or without Lung Transplantation
Francesca Lucca, Valentino Bezzerri, Elisa Danese, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 908-908
Open Access | Times Cited: 9
SARS-CoV-2 infection in cystic fibrosis: A multicentre prospective study with a control group, Italy, February-July 2020
Carla Colombo, Gianfranco Alicandro, Valeria Daccò, et al.
PLoS ONE (2021) Vol. 16, Iss. 5, pp. e0251527-e0251527
Open Access | Times Cited: 22
COVID-19 outcomes in people with cystic fibrosis
Pierre‐Régis Burgel, Christopher H. Goss
Current Opinion in Pulmonary Medicine (2021) Vol. 27, Iss. 6, pp. 538-543
Open Access | Times Cited: 20
The genetic and evolutionary determinants of COVID-19 susceptibility
Gaspard Kerner, Lluı́s Quintana-Murci
European Journal of Human Genetics (2022) Vol. 30, Iss. 8, pp. 915-921
Open Access | Times Cited: 14
The clinical impact of the Covid-19 pandemic first wave on patients with cystic fibrosis in New York
Joseph L. Simonson, Christine Tanaka Esposito, T. Frantzen, et al.
Journal of Cystic Fibrosis (2022) Vol. 21, Iss. 3, pp. e176-e183
Open Access | Times Cited: 11
Cumulative Incidence and Risk Factors for Severe Coronavirus Disease 2019 in French People With Cystic Fibrosis
Harriet Corvol, Sandra de Miranda, Clémence Dehillotte, et al.
Clinical Infectious Diseases (2022) Vol. 75, Iss. 12, pp. 2135-2144
Open Access | Times Cited: 11
The impact of SARS-CoV-2 infection in patients with cystic fibrosis undergoing CFTR channel modulators treatment: a literature review
Antonio Vitiello, Michela Sabbatucci, Andrea Silenzi, et al.
Respiratory Research (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 5
The Impact of COVID-19 in Cystic Fibrosis
Patrick A. Flume, Lisa Saiman, Bruce C. Marshall
Archivos de Bronconeumología (2021) Vol. 58, Iss. 6, pp. 466-468
Open Access | Times Cited: 13
Flagellin From Pseudomonas aeruginosa Modulates SARS-CoV-2 Infectivity in Cystic Fibrosis Airway Epithelial Cells by Increasing TMPRSS2 Expression
Manon Ruffin, Jeanne Bigot, Claire Calmel, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 12
Epidemiological Profile of Hospitalized Patients with Cystic Fibrosis in Brazil Due to Severe Acute Respiratory Infection during the COVID-19 Pandemic and a Systematic Review of Worldwide COVID-19 in Those with Cystic Fibrosis
Leonardo Souza Marques, Matheus Negri Boschiero, Nathália Mariana Santos Sansone, et al.
Healthcare (2023) Vol. 11, Iss. 13, pp. 1936-1936
Open Access | Times Cited: 4
Mechanisms by which the cystic fibrosis transmembrane conductance regulator may influence SARS‐CoV‐2 infection and COVID‐19 disease severity
Philip R. Tedbury, Candela Manfredi, Frauke Degenhardt, et al.
The FASEB Journal (2023) Vol. 37, Iss. 11
Closed Access | Times Cited: 4
Risk factors for admission to the pediatric critical care unit among children hospitalized with COVID-19 in France
Blandine Prévost, A. Retbi, F. Binder-Foucard, et al.
Frontiers in Pediatrics (2022) Vol. 10
Open Access | Times Cited: 6
Impact of COVID-19 in Children with Chronic Lung Diseases
Valentina Ferraro, Stefania Zanconato, Silvia Carraro
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 18, pp. 11483-11483
Open Access | Times Cited: 6
Crosslink between SARS-CoV-2 replication and cystic fibrosis hallmarks
Virginia Lotti, Anna Lagni, Erica Diani, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 3
Chronic respiratory diseases other than asthma in children: the COVID-19 tsunami
Maria Di Cicco, Maria Giulia Tozzi, Vincenzo Ragazzo, et al.
˜The œItalian Journal of Pediatrics/Italian journal of pediatrics (2021) Vol. 47, Iss. 1
Open Access | Times Cited: 8
Impact of COVID-19 on Lung Disease in People with Cystic Fibrosis: A 6-Month Follow-Up Study on Respiratory Outcomes
Paola Medino, Gianfranco Alicandro, Chiara Rosazza, et al.
Biomedicines (2022) Vol. 10, Iss. 11, pp. 2771-2771
Open Access | Times Cited: 5
Impact of the COVID-19 pandemic and associated lockdown measures on the management, health, and behavior of the cystic fibrosis population in France during 2020 (MUCONFIN)
Nadia Oubaya, Thibaud Pombet, Céline Delestrain, et al.
Frontiers in Public Health (2022) Vol. 10
Open Access | Times Cited: 4
A COVID–19-fertőzéssel és -immunizációval szerzett tapasztalatok felnőtt cystás fibrosisos betegcsoportban
Zoltán Örlős, Zsuzsanna Miklós, Ildikó Horváth
Orvosi Hetilap (2024) Vol. 165, Iss. 9, pp. 332-337
Open Access
Page 1 - Next Page

Scroll to top